InvestorsHub Logo
Followers 3
Posts 964
Boards Moderated 0
Alias Born 03/30/2021

Re: TooFrank post# 5156

Thursday, 03/28/2024 12:35:43 PM

Thursday, March 28, 2024 12:35:43 PM

Post# of 5329
Exactly. Very confusing to not lead off with the revenue generating product that is already FDA cleared, and is being manufactured by an ISO-13485 certified manufacturer and is being marketed by a very knowledgeable team at Verséa Ophthalmics. Very interesting.


However the video does make me think that the Parkinsons disease test must be generating a lot of interest from one or more Big Pharma companies. Since it is a Tear-based Point-of-Care quantitative Diagnostics test one would think it would play well in the EyeCare space.


Is it rock solid interest?
Is it backed up by $$Millions in a down payment AND residual $ dollars to AXIM for each test?


More questions than answers.



Hashtags related to our company and partners.

Merchandising partner:
#VerséaOphthalmics
#VerséaHealth
#TPOC Tear based Point-of-Care
#DryEye #Diagnostics #Quantitative
#Lactoferrin #TotalIgE
#TPOCTITAN #TPOCTITANS

Manufacturing Partner:
#AuerPrecision ISO Certified
#ISO9001 #ISO13485

#AXIMBIOTECH
#AXIMEYE #DryEye
#Parkinsons #TPOC #Diagnostics
#Lactoferrin #510K
510(k) Number K934473
#TotalIgE #510K
510(k) Number. K991316


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News